Table II.
40-meter Fast-Paced Walk Test (40-m FPWT) differences at baseline, and changes immediately after exercise therapy and education between participants with and without comorbidities
|
Baseline 40-m FPWT Mean m/s (95% CI) |
3 mo. 40-m FPWT Mean m/s (95% CI) |
Change 3 mo. 40-m FPWT Mean m/s (95% CI) |
|
| No comorbidities, n = 12,128 |
1.56 (1.56–1.57) |
1.69 (1.68–1.69) |
0.12 (0.12–0.13) |
|
Difference at baseline |
Difference in change at 3 months |
||
| Mean m/s (95% CI) |
Unadjusted mean m/s (95% CI) |
Adjusted∗ mean m/s (95% CI) |
|
| HT, n = 5,716 | −0.12 (−0.13 to −0.11) | −0.00 (−0.01 to 0.01) | −0.00 (−0.01 to 0.01) |
| HT + DM, n = 729 | −0.22 (−0.25 to −0.20) | −0.00 (−0.03 to 0.01) | 0.00 (−0.02 to 0.02) |
| HT + HD, n = 630 | −0.17 (−0.19 to −0.14) | −0.01 (−0.03 to 0.01) | −0.01 (−0.03 to 0.01) |
| Resp, n = 558 | −0.07 (−0.10 to −0.04) | −0.01 (−0.03 to 0.01) | −0.01 (−0.03 to 0.01) |
| HD, n = 551 | −0.09 (−0.11 to −0.06) | −0.01 (−0.03 to 0.01) | −0.01 (−0.03 to 0.01) |
| Neu, n = 508 | −0.05 (−0.08 to −0.03) | 0.00 (−0.02 to 0.02) | 0.00 (−0.02 to 0.02) |
| RA, n = 501 | −0.06 (−0.09 to −0.04) | 0.02 (−0.00 to 0.04) | 0.02 (−0.00 to 0.04) |
| Ulcer, n = 447 | −0.05 (−0.08 to −0.02) | −0.01 (−0.03 to 0.01) | −0.01 (−0.04 to 0.01) |
| Dep, n = 408 | −0.09 (−0.12 to −0.06) | 0.01 (−0.02 to 0.04) | 0.01 (−0.02 to 0.04) |
| DM, n = 358 | −0.15 (−0.18 to −0.11) | −0,01 (−0.04 to 0.01) | −0.01 (−0.04 to 0.01) |
| HT + Resp, n = 323 | −0.20 (−0.24 to −0.17) | −0.02 (−0.05 to 0.00) | −0.03 (−0.05 to 0.00) |
| HT + RA, n = 275 | −0.14 (−0.18 to −0.10) | −0.03 (−0.06 to 0.00) | −0.03 (−0.06 to 0.00) |
| HT + Neu, n = 274 | −0.14 (−0.18 to −0.10) | 0.01 (−0.02 to 0.04) | 0.01 (−0.02 to 0.04) |
| HT + Ulcer, n = 254 | −0.16 (−0.20 to −0.12) | 0.02 (−0.01 to 0.05) | 0.02 (−0.01 to 0.05) |
| Cancer, n = 234 | −0.06 (−0.10 to −0.02) | 0.01 (−0.02 to 0.04) | 0.01 (−0.02 to 0.04) |
| HT + Dep, n = 203 | −0.21 (−0.26 to −0.17) | 0.01 (−0.02 to 0.05) | 0.01 (−0.02 to 0.05) |
| HT + Cancer, n = 137 | −0.16 (−0.22 to −0.11) | −0.01 (−0.05 to 0.04) | −0.01 (−0.05 to 0.04) |
| HT + HD + DM, n = 117 | −0.26 (−0.32 to −0.20) | 0.01 (−0.04 to 0.06) | 0.01 (−0.04 to 0.06) |
| Anemia, n = 83 | −0.04 (−0.11 to 0.03) | −0.06 (-0.11 to -0.1) | −0.06 (-0.11 to -0.01) |
| HT + Ren/Liv. n = 79 | −0.09 (−0.16 to −0.02) | −0.03 (−0.08 to 0.02) | −0.03 (−0.08 to 0.02) |
| Number of comorbidities | |||
| 1 comorbidity, n = 9,441 | −0.10 (−0.11 to −0.9) | −0.00 (−0.01 to 0.01) | −0.00 (−0.01 to 0.01) |
| 2 comorbidities, n = 3,838 | −0.17 (−0.19 to −0.17) | −0.01 (−0.01 to 0.00) | −0.01 (−0.01 to 0.00) |
| 3 comorbidities, n = 1,173 | −0.23 (−0.25 to −0.21) | −0.00 (−0.02 to 0.01) | −0.00 (−0.02 to 0.01) |
| ≥4 comorbidities, n = 392 | −0.31 (−0.34 to −0.28) | 0.01 (−0.02 to 0.03) | 0.01 (−0.02 to 0.03) |
n: Number, CI: Confidence interval. HT: Hypertension, DM: Diabetes mellitus one or 2, Resp: Respiratory disease, HD: Heart disease, Neu: Neurologic disease, RA: Rheumatoid arthritis, Dep: Depression, Ren/Liv: Renal and/or liver disease.
∗
Adjusted for age, sex, BMI, educational level, not born in Denmark, civil status, physical activity, problems in other joints, use of analgesics, and number of bodily pain areas. Estimates in bold reflect statistical significance (P < 0.05).